IMABEQ Trademark

Trademark Overview

On Tuesday, April 6, 2004, a trademark application was filed for IMABEQ with the United States Patent and Trademark Office. The USPTO has given the IMABEQ trademark a serial number of 79002285. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Sunday, April 6, 2014. This trademark is owned by Merck KGaA. The IMABEQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the prevention and treatment of cancer
imabeq

General Information

Serial Number79002285
Word MarkIMABEQ
Filing DateTuesday, April 6, 2004
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSunday, April 6, 2014
Registration Number3011571
Registration DateTuesday, November 1, 2005
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 9, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the prevention and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 17, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck KGaA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Thursday, October 30, 2014NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Thursday, October 30, 2014DEATH OF INTERNATIONAL REGISTRATION
Thursday, September 18, 2014TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, June 28, 2014TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, January 17, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, May 17, 2013CANCELLED SECTION 71
Friday, August 31, 2007FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, July 17, 2006FINAL DISPOSITION NOTICE SENT TO IB
Monday, July 17, 2006FINAL DISPOSITION PROCESSED
Monday, June 19, 2006FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, November 17, 2005NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, November 1, 2005REGISTERED-PRINCIPAL REGISTER
Thursday, October 27, 2005NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, October 27, 2005NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, August 9, 2005PUBLISHED FOR OPPOSITION
Wednesday, July 20, 2005NOTICE OF PUBLICATION
Friday, April 22, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 15, 2005ASSIGNED TO LIE
Tuesday, April 12, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 1, 2005AMENDMENT FROM APPLICANT ENTERED
Thursday, March 17, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 17, 2005PAPER RECEIVED
Thursday, December 9, 2004REFUSAL PROCESSED BY IB
Wednesday, November 3, 2004NON-FINAL ACTION MAILED
Thursday, October 28, 2004NON-FINAL ACTION WRITTEN
Wednesday, October 27, 2004ASSIGNED TO EXAMINER
Friday, May 28, 2004NEW APPLICATION ENTERED IN TRAM
Thursday, May 27, 2004SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

imabeq treatment cancer prevention human preparations pharmaceutical